Bill Status of HB1721  102nd General Assembly


House Sponsors
Rep. Deanne M. Mazzochi - Carol Ammons, Jonathan Carroll, Ryan Spain and La Shawn K. Ford

Last Action
DateChamber Action
  1/10/2023HouseSession Sine Die

Statutes Amended In Order of Appearance
410 ILCS 620/3.24 new

Synopsis As Introduced
Amends the Illinois Food, Drug and Cosmetic Act. Requires a manufacturer of a prescription drug that is sold, offered for sale, or distributed in this State, or placed on a formulary to be eligible for payment, co-payment, or reimbursement in this State, to notify the Department of Public Health of specified information concerning active pharmaceutical ingredients.

DateChamber Action
  2/11/2021HouseFiled with the Clerk by Rep. Deanne M. Mazzochi
  2/17/2021HouseFirst Reading
  2/17/2021HouseReferred to Rules Committee
  3/9/2021HouseAssigned to Consumer Protection Committee
  3/9/2021HouseAdded Co-Sponsor Rep. Jonathan Carroll
  3/15/2021HouseDo Pass / Consent Calendar Consumer Protection Committee; 006-000-000
  3/18/2021HousePlaced on Calendar 2nd Reading - Consent Calendar
  4/6/2021HouseAdded Chief Co-Sponsor Rep. Carol Ammons
  4/14/2021HouseSecond Reading - Consent Calendar
  4/14/2021HouseHeld on Calendar Order of Second Reading - Consent Calendar
  4/14/2021HouseAdded Co-Sponsor Rep. Ryan Spain
  4/14/2021HouseAdded Co-Sponsor Rep. La Shawn K. Ford
  4/14/2021HouseRemoved from Consent Calendar Status Rep. Greg Harris
  4/14/2021HouseHeld on Calendar Order of Second Reading - Short Debate
  4/23/2021HouseRule 19(a) / Re-referred to Rules Committee
  1/10/2023HouseSession Sine Die